[1]
M. Amir, U. . Ali, A. Javed, and J. . Ahmad, “UTILITY OF INFLAMMATORY MARKERS FOR TOCILIZUMAB IN COVID-19 PATIENTS: A SINGLE-SITE RETROSPECTIVE STUDY”, J Ayub Med Coll Abbottabad, vol. 34, no. 4, pp. 781–785, Sep. 2022.